Back to Polar Capital Holdings Plc Polar Capital Holdings Plc

CYTKCYTK

Showing 8 of 23 quarters

Position history for Polar Capital Holdings PlcPolar Capital Holdings Plc's holdings in CYTOKINETICS INC

Yes. Polar Capital Holdings holds 2,253,649 shares of CYTK (Cytokinetics), worth $192M, as of its Q2 2026 13F filing. It increased the position by 592,401 shares (+35.7%) from Q1 2026. Polar Capital Holdings has held CYTK in every 13F on record since Q4 2020, 23 quarterly filings. CYTK is 0.5% of Polar Capital Holdings' reported 13F portfolio.

Current Value

$192M

Current Shares

2.3M

Total Value Change

+$68.6M

Total Shares Change

-84,198

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.3M
+35.7%
$192M0.5%$85.19
47
2026-Q1
Decreased
1.7M
-31.4%
$109.5M0.4%$65.91
0
2025-Q4
Decreased
2.4M
-12.9%
$153.9M0.6%$63.54
0
2025-Q3
Decreased
2.8M
-0.6%
$152.9M0.7%$54.96
0
2025-Q2
Increased
2.8M
+13.9%
$92.5M0.5%$33.04
41
2025-Q1
Increased
2.5M
+11.8%
$98.7M0.6%$40.19
47
2024-Q4
Decreased
2.2M
-6.0%
$103.3M0.6%$47.04
0
2024-Q3
Decreased
2.3M
-4.8%
$123.4M0.6%$52.80
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used